(Q24234216)

English

Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery

scientific article (publication date: 7 July 2010)

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery (English)

0 references

proliferative vitreoretinopathy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

0 references

author name string

Venki Sundaram

1

0 references

Allon Barsam

2

0 references

publication date

7 July 2010

0 references

Cochrane Database of Systematic Reviews

0 references

Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

Prevention of proliferative vitreoretinopathy using 5-FU heparin: clinical tolerance and efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

Taxol treatment of experimental proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

Primary vitrectomy for rhegmatogenous retinal detachment: an analysis of 512 cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

Changing Concepts of Failures After Retinal Detachment Surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

21 January 2018

Oral colchicine for the treatment of experimental traction retinal detachment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of Intraocular Proliferations with Intravitreal Corticosteriods

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucocorticosteroid inhibition of intraocular proliferation after injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

An overview of potential applications of heparin in vitreoretinal surgery.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006421.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24234216&oldid=1694476705"